Pages

Showing posts with label Sarilumab. Show all posts
Showing posts with label Sarilumab. Show all posts

Tuesday, 15 June 2021

What progress are we making on treatments? Coronavirus Cure

 The UK government has announced it's setting up a new taskforce to investigate antiviral treatments coronavirus patients can take at home.

By James Gallagher

Health and science correspondent

Published
comments
 2021 Comments
Related Topics
Woman in hospital bedIMAGE COPYRIGHTGETTY IMAGES

The UK government has announced it's setting up a new taskforce to investigate antiviral treatments coronavirus patients can take at home.

It says the aim is to identify at least two effective treatments this year, in the form of pills, to help people fight off early Covid symptoms.

Alongside Covid-19 vaccines, a number of drugs are being tested as possible treatments for people who already have the disease.

Most of these are existing drugs that are being trialled against the virus.

What work is being done to find treatments?

  • The UK is running the the world's largest clinical trial, called Recovery, with more than 12,000 patients taking part - it is one of the few trials to have given a definitive view on which drugs do and do not work
  • The World Health Organization (WHO) is running the the Solidarity trial to assess promising treatments in countries around the world
  • The Principle trial - run by the University of Oxford - is looking for medicines which will help people recover from Covid symptoms at home
  • Multiple pharmaceutical companies are running trials of their own drugs

There are three broad approaches being investigated:

  • Antiviral drugs that directly affect the coronavirus's ability to thrive inside the body
  • Drugs that calm the immune system (severe Covid-19 is caused by patients' immune systems overreacting and damaging the body)
  • Antibodies that can target the virus, taken from either survivors' blood plasma or made in a lab

It is possible that different drugs will work better at different stages - such as antivirals at the beginning and immune drugs in late-stage diseases. Combinations of therapies will also be investigated.

Steroid treatments

The steroid dexamethasone has been shown to cut the risk of death by a third for patients on ventilators and by a fifth for those on oxygen.

Further data suggests another steroid, hydrocortisone, is equally effective too.

Both calm down inflammation (part of the immune response) in the body, which can become damaging in severe cases.

Crucially, dexamethasone is also cheap which means it could be used all around the world.

However, the drug does not work on people with milder symptoms.

How patients on ventilators would fare on dexamethasone

A steroid drug commonly used to treat asthma has been shown to help vulnerable people with early Covid symptoms recover more quickly at home.

After encouraging early trial results, the NHS says budesonide can now by prescribed by GPs as an inhaler.

Tocilizumab and sarilumab

Researchers report encouraging results from two anti-inflammatory medications, tocilizumab and sarilumab.

In a trial carried out in six different countries, including the UK, with about 800 intensive care patients, the drugs reduced the number of deaths from 36% to 27%.

Another study, called RECOVERY, also found tocilizumab added to the life-saving effects of dexamethasone.

Tocilizumab and sarilumab dampen down inflammation, which can go into overdrive in Covid patients and cause damage to the lungs and other organs.

Doctors could give them to a Covid patient who, despite receiving dexamethasone, is still deteriorating and needs intensive care.

The research findings have not yet been peer-reviewed or published in a medical journal.

Interferon beta

Interferon beta, a protein which the body produces when it gets a viral infection, is at the centre of a large trial in the UK.

It's being given to hospitalised Covid patients in the form of a spray which is inhaled.

The hope is that the drug will stimulate the immune system, priming cells to be ready to fight off viruses.

Early findings suggest interferon beta (which is normally used for treating multiple sclerosis) could cut the odds of a Covid patient in hospital developing severe disease - such as requiring ventilation - by almost 80%.

What other drugs have been trialled?

Remdesivir is an antiviral drug - originally developed to treat Ebola - that showed promising early results.

However, in October 2020, the World Health Organization advised against its use for Covid, saying that it "appeared to have little or no effect on hospitalised Covid", in terms of either death rates, length of stay in hospital, or seriousness of illness.

Banner image reading 'more about coronavirus'

What do I need to know about the coronavirus?

Banner

Can malaria drugs stop coronavirus?

Chloroquine, and the related drug, hydroxychloroquine, may have antiviral and immune-calming properties.

The drugs were thrust into the spotlight as potential coronavirus therapies, largely because of claims made by President Trump, and because early laboratory tests showed they could inhibit the coronavirus.

media captionEpidemic v pandemic: What's the difference?

Can survivors' blood treat coronavirus?

People who survive an infection should have antibodies in their blood that can attack the virus.

Blood plasma (the part which contains the antibodies) can be extracted from those who have recovered and then given to sick patients as "convalescent plasma".

It was hoped transfusing seriously-ill patients with the plasma could give struggling immune systems a helping hand.

But a trial in hospital patients found using blood plasma does not reduce deaths or improve outcomes for those in intensive care.

However international trials are continuing to examine if plasma might help much earlier in the disease, before people get to hospital. Blood plasma is still being collected in the UK.

The US Food and Drug Administration (FDA) has given emergency authorisation for the use of plasma to treat coronavirus patients based on promising results from early trials - although some experts say it's too soon to know how effective the treatment is.

media captionAnn "felt so well" after being given plasma from patients who recovered from Covid-19

Why do we need treatments as well as vaccines?

While vaccines can stop people from contracting Covid and becoming seriously ill, treatments will still be needed for those who already have it.

Having an effective treatment would, in essence, make coronavirus a milder disease.

If it stopped people with Covid at home from needing hospital treatment or stopped those admitted to hospital from needing ventilation, then there would be less risk of hospitals and intensive care units being overwhelmed.

Follow James on Twitter


https://www.bbc.com/news/health-52354520

Thursday, 7 January 2021

BBC: Two more life-saving Covid drugs discovered

 Two more life-saving drugs have been found that can cut deaths by a quarter in patients who are sickest with Covid.

By Michelle Roberts
Health editor, BBC News online

Published
7 January 2021


The anti-inflammatory medications, given via a drip, save an extra life for every 12 treated, say researchers who have carried out a trial in NHS intensive care units.

Supplies are already available across the UK so they can be used immediately to save hundreds of lives, say experts.

There are over 30,000 Covid patients in UK hospitals - 39% more than in April.

The UK government is working closely with the manufacturer, to ensure the drugs - tocilizumab and sarilumab - continue to be available to UK patients.

As well as saving more lives, the treatments speed up patients' recovery and reduce the length of time that critically-ill patients need to spend in intensive care by about a week.

Both appear to work equally well and add to the benefit already found with a cheap steroid drug called dexamethasone.

Although the drugs are not cheap, costing around £750 to £1,000 per patient, on top of the £5 course of dexamethasone, the advantage of using them is clear - and less than the cost per day of an intensive care bed of around £2,000, say experts.

Lead researcher Prof Anthony Gordon, from Imperial College London, said: "For every 12 patients you treat with these drugs you would expect to save a life. It's a big effect."

In the REMAP-CAP trial carried out in six different countries, including the UK, with around 800 intensive care patients:

  • Nearly 36% of intensive care Covid patients receiving standard care died
  • The new drugs reduced that by a quarter, to 27%, when given to patients within 24 hours of them entering intensive care

Prof Stephen Powis, NHS national medical director, said: "The fact there is now another drug that can help to reduce mortality for patients with Covid-19 is hugely welcome news and another positive development in the continued fight against the virus."

Health and Social Care Secretary Matt Hancock said: "The UK has proven time and time again it is at the very forefront of identifying and providing the most promising, innovative treatments for its patients.

"Today's results are yet another landmark development in finding a way out of this pandemic and, when added to the armoury of vaccines and treatments already being rolled out, will play a significant role in defeating this virus."

The drugs dampen down inflammation, which can go into overdrive in Covid patients and cause damage to the lungs and other organs.

Doctors are being advised to give them to any Covid patient who, despite receiving dexamethasone, is deteriorating and needs intensive care.

Tocilizumab and sarilumab have already been added to the government's export restriction list, which bans companies from buying medicines meant for UK patients and selling them on for a higher price in another country.

The research findings have not yet been peer reviewed or published in a medical journal.


https://www.bbc.com/news/health-55574662